SlideShare ist ein Scribd-Unternehmen logo
1 von 1
Downloaden Sie, um offline zu lesen
3
2
1
Abstract:
Loss,	sadness,	and	isolation	– the	devastating	feelings	35	million	Alzheimer’s	patients	worldwide	must	wrestle	on	a	daily	basis.	Alzheimer’s	is	a	
neurodegenerative	disease	characterized	by	brain	mass	loss.	Using	Cobweb,	a	better	understanding	of	the	mechanisms	that	underliethis	
disease	can	be	achieved,	facilitating	the	creation	of	new	treatments.	According	to	the	Amyloid	Cascade	Hypothesis,	amyloid	beta	is	the	cause	of	
this	degeneration.	Neurons,	the	cells	in	our	nervous	system,	produce	this	transmembrane	protein	which	a	series	of	enzymes,	namely	beta	
secratase,	cut	and	release.	It	then	clumps	and	wreaks	havoc	on	synapses,	the	connections	between	neurons.	Normally,	these	proteins	are	
swept	out	of	the	brain	by	cerebral	spinal	fluid	(CSF),	while	in	Alzheimer’s,	there	is	a	decrease	in	the	efficiency	of	this	cleaning	mechanism,	which	
we	have	been	able	to	illustrate	in	Cobweb.	As	a	result,	amyloid	beta	aggregates	and	interferes	in	neuronal	communication,	becoming	the	
catalyst	for	the	formation	of	neurofibrillary	tangles,	which	are	dead	nerve	cells.	Both	of	these	phenomena	are	successfully	realized	in	our	
model.	The	combination	of	plaques	and	tangles	causes	brain	mass	loss,	the	cause	of	the	manifestation	of	symptoms.
The	Brain	on	COBWEB
A	Hierarchy,	Revisited
Alessandro	Ricci,	Melisa	Gumus,	Mazen El-Kurdi,	
Vernon	Li,	Victoria	Agapova
Supervisor:	Dr.	Brad	Bass
Purpose	- To	successfully	model	the	progress	of	Alzheimer’s	in	the	brain	using	Cobweb.
Hypothesis	- We	hypothesize	that	we	can	monitor	the	brain	of	an	Alzheimer’s	patient	from	birth	to	neurodegeneration	by	illustrating	its	
components	on	Cobweb,	software	originally	meant	to	explore	theoretical	complex	systems.
Legend
- Glucose- A	Hippocampal	
Neuron
- Cerebral	Spinal	Fluid	
(CSF)	and	interstitial	fluid
- Amyloid	Beta	(represented	
as	a	product	of	a	neuron)
- Cerebral	Spinal	Fluid	(CSF)	
and	interstitial	fluid
Results
Fig	1	– A	representation	of	the	healthy	adult	brain	in	Cobweb.	The	top	4/5	
of	the	image	is	the	hippocampus	with	neurons	and	normally	forming	
amyloid	beta	being	produced	and	flushed	away.	
Fig	2	– The	final	stage	of	Alzheimer’s,	with	significant	brain	cell	loss,	amyloid	
beta	plaques,	and	neurofibrillary	tangles	(dead	hippocampal	neurons).
Fig	3	– The	graphical	representation	of	the	hippocampal	cell	
count,	with	initial	rapid	growth	representing	early	
neurodevelopment	(1),	relative	stabilization	in	adulthood	(2),	
and	the	rapid	decline	in	Alzheimer’s.	(3)
Fig	4	– An	amyloid	beta	immunostain.	Source	:	Grathwohl,	
S.A.,	Kälin,	R.E.,	Bolmont,	T.,	Prokop,	S.,	Winkelmann,	G.,	Kaeser,	S.A.,	
Odenthal,	J.,	Radde,	R.,	Eldh,	T.,	Gandy,	S.,	et	al.	(2009).	Formation	and	
maintenance	of	Alzheimer’s	disease	β-amyloid	plaques	in	the	absence	
of	microglia.	Nature	Neuroscience	12,	1361–1363.
Conclusion	- Computer	models	afford	a	different	perspective	on	human	systems	and	difficult	diseases.	Alzheimer’s,	being	one	of	them.	
Scientists	do	not	yet	have	a	clear	understanding	of	its	onset	or	mechanism	of	destruction.	A	model	created	on	Cobweb	can	act	as	a	vessel	
through	which	potential	treatments	can	be	tested	for	efficacy.	An	important	concern	is	the	delicacy	of	a	computer	simulation, where	adding	
another	parameter,	be	it	a	treatment,	may	change	the	original	project	itself.	Creating	a	more	stable	model	is	a	critical	goal for	future	research.
Fig	1	- Propagation	
of	one	IPSP	and	
three	EPSPs	coming	
from	the	dendrites
Fig	2	- Propagation	
of	IPSP	
outcompeting	a	
sum	of	three	EPSPs	
due	to	its	strategic	
location	close	to	an	
axon	hillock
Fig	3	- When	no	IPSP	
is	present,	the	
summation	of	three	
EPSPs	causes	neuron	
potential	to	reach	
threshold	and	
activate	action	
potential
Post	Synaptic	Potential	-
Abstract:
When	using	computerized	simulations	such	as	COBWEB	to	model	brain	activity,	it	is	difficult	to	obtain	an	accurate	representationof	such	a	vast	neural	network.	This	idea	stresses	the	importance	of	
deconstruction	and	the	separation	of	neural	activity	into	the	three	basic	signalling	principles	of	action	potential	transmission,	synaptic	transmission	and	post	synaptic	potential	propagation.	An	action	
potential	is	an	event	in	which	electrical	charges	across	a	cell	membrane	rises	and	falls.	The	change	in	membrane	potential	leads to	the	ability	of	electrical	signalling	in	neurons.	This	model	simulates	one	
action	potential	between	two	neurons.	It	uses	COBWEB	to	represent	sodium	and	potassium	movement	which	demonstrates	the	changes	in	membrane	potential.	The	idea	of	ion	movement	in	COBWEB	is	
applied	by	the	theory	of	predator	prey	models.	With	the	execution	of	an	action	potential,	the	signal	is	carried	downstream	to the	presynaptic	membrane	where	neurotransmitters	are	released	into	the	
synaptic	cleft.	Synaptic	transmission	refers	to	the	communication	between	two	neurons	via	the	synapse.	When	the	action	potential	arrives	at	the	axon	terminal	it	alters	the	membrane	potential	in	that	
area,	which	results	in	the	release	of	neurotransmitters,	which	can	then	travel	to	the	post	synaptic	membrane	of	another	neuron	and	bind	to	receptors	there.	After	that	occurs	it	results	in	the	initiation	of	
another	action	potential	in	that	neuron.	Hence	communication	has	occurred	between	the	adjacent	neurons.	This	model	presents	this phenomenon	showing	an	action	potential	arriving	at	the	axon	
terminal	and	subsequently	being	communicated	to	the	next	neuron.	The	opening	of	ion	channels	on	the	post	synaptic	membrane	triggers	Excitatory	Postsynaptic	Potentials	(EPSPs)	and	allows	the	
potential	to	reach	a	threshold	that	triggers	action	potential,	whereas	summation	of	Inhibitory	Postsynaptic	Potentials	(IPSPs)	prevents	potential	from	reaching	threshold	thus	inhibiting	action	potential.	
Not	only	is	the	amplitude	of	IPSPs	and	EPSPs	important	for	signal	propagation,	but	also	the	site	of	their	arrival	to	cell	soma.	This	simulation	model	demonstrates	a	single	IPSP	preventing	action	potential	
activation	by	three	incoming	EPSPs	due	to	its	beneficial	location	closer	to	the	axon	hillock.
Figure	1: Yellow	Agents	(Potassium)	and	Blue	
Agents	(Sodium)	interacting	at	the	peak	of	the	
action	potential.	This	map	shows	the	charge	
represented	by	agents.	Because	there	are	more	
blue	agents	(sodium)	vs	yellow	(potassium),	we	
can	interpret	that	the	charge	at	the	peak	of	the	
action	potential	is	mainly	due	to	sodium.
Figure	2:	Blue	agents	(sodium)	is	no	longer	dominant	and	
the	figure	above	represents	the	phase	of	
hyperpolarization.	As	depicted,	there	are	more	yellow	
agents	(potassium)	than	blue	agents	(sodium).	This	
means	that	the	charge	in	the	hyperpolarization	phase	is	
mainly	due	to	the	action	of	potassium.
Figure	4:	The	effect	of	sodium	and	potassium	ions	inside	the	cell	when	
forming	an	action	potential.	With	an	initial	stimuli,	sodium	enters	the	
cell	represented	by	the	orange	curve.	At	first,	sodium	plays	a	larger	
role,	but	as	the	action	potential	continues,	at	1000	ticks,	potassium	
plays	a	bigger	role	when	it	comes	to	hyperpolarization.	This	is	
represented	by	the	potassium	count	being	greater	than	the	sodium	
count.		
0
500
1000
1500
2000
2500
0 200 400 600 800 1000 1200 1400 1600
Agent	Count	(K+/Na+)
Time	(Ticks)
Amount	of	Sodium	and	Potassium	Ions	Inside	the	Cell	Over	Time.
Potassium
Sodium
Figure	3:	Representation	of	an	action	potential	
caused	by	the	potassium	and	sodium	movement	
across	the	cell	membrane.	The	red	line	depicts	
the	agents	which	are	potassium	and	sodium	and	
the	red	curve	shows	their	effect	together,	thus	
resulting	in	an	action	potential.
Action	Potential	-
The	Synapse	-
Healthy	Brain	Model Alzheimer’s	Model
Acknowledgements	– We	thank	Dr.	Brad	Bass	for	his	guidance	and	advice,	and	our	research	assistants	Jason	Ning	and	Angelina	Pan	for	their	
help.
ROP299
Fig	1 Fig	2 Fig	3 Fig	4

Weitere ähnliche Inhalte

Was ist angesagt?

Glial cells and astrocytes: neural networks modulators?
Glial cells and astrocytes: neural networks modulators?Glial cells and astrocytes: neural networks modulators?
Glial cells and astrocytes: neural networks modulators?Stephen Larroque
 
Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's diseaseSruthi Sony
 
Neuroplasticity by Reagon Heikes
Neuroplasticity by Reagon HeikesNeuroplasticity by Reagon Heikes
Neuroplasticity by Reagon HeikesReagon Cara
 
Review Nature 399 A15
Review Nature 399 A15Review Nature 399 A15
Review Nature 399 A15MADHU.MATHEWS
 
Neuroplasticity
Neuroplasticity Neuroplasticity
Neuroplasticity ishasonkar2
 
The nano skeleton in the closet
The nano skeleton in the closetThe nano skeleton in the closet
The nano skeleton in the closetAdonis Sfera, MD
 
Cadth 2015 c5 1. cashman rare diseases
Cadth 2015 c5 1. cashman rare diseasesCadth 2015 c5 1. cashman rare diseases
Cadth 2015 c5 1. cashman rare diseasesCADTH Symposium
 
Protein misfolding diseases
Protein misfolding diseasesProtein misfolding diseases
Protein misfolding diseasesNamrata Chhabra
 
Konstantin Ravvin (Sackler Journal of Medicine): The Biochemical Foundations...
Konstantin Ravvin (Sackler Journal of Medicine):  The Biochemical Foundations...Konstantin Ravvin (Sackler Journal of Medicine):  The Biochemical Foundations...
Konstantin Ravvin (Sackler Journal of Medicine): The Biochemical Foundations...Konstantin Ravvin
 
Multiple Sclerosis Recovery
Multiple Sclerosis RecoveryMultiple Sclerosis Recovery
Multiple Sclerosis Recoveryguestb99c9a
 
Neuronal plasticity
Neuronal plasticityNeuronal plasticity
Neuronal plasticitySyed Nadir
 

Was ist angesagt? (11)

Glial cells and astrocytes: neural networks modulators?
Glial cells and astrocytes: neural networks modulators?Glial cells and astrocytes: neural networks modulators?
Glial cells and astrocytes: neural networks modulators?
 
Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's disease
 
Neuroplasticity by Reagon Heikes
Neuroplasticity by Reagon HeikesNeuroplasticity by Reagon Heikes
Neuroplasticity by Reagon Heikes
 
Review Nature 399 A15
Review Nature 399 A15Review Nature 399 A15
Review Nature 399 A15
 
Neuroplasticity
Neuroplasticity Neuroplasticity
Neuroplasticity
 
The nano skeleton in the closet
The nano skeleton in the closetThe nano skeleton in the closet
The nano skeleton in the closet
 
Cadth 2015 c5 1. cashman rare diseases
Cadth 2015 c5 1. cashman rare diseasesCadth 2015 c5 1. cashman rare diseases
Cadth 2015 c5 1. cashman rare diseases
 
Protein misfolding diseases
Protein misfolding diseasesProtein misfolding diseases
Protein misfolding diseases
 
Konstantin Ravvin (Sackler Journal of Medicine): The Biochemical Foundations...
Konstantin Ravvin (Sackler Journal of Medicine):  The Biochemical Foundations...Konstantin Ravvin (Sackler Journal of Medicine):  The Biochemical Foundations...
Konstantin Ravvin (Sackler Journal of Medicine): The Biochemical Foundations...
 
Multiple Sclerosis Recovery
Multiple Sclerosis RecoveryMultiple Sclerosis Recovery
Multiple Sclerosis Recovery
 
Neuronal plasticity
Neuronal plasticityNeuronal plasticity
Neuronal plasticity
 

Andere mochten auch

Pinta&Usa Fascículo - Fashionista
Pinta&Usa Fascículo - FashionistaPinta&Usa Fascículo - Fashionista
Pinta&Usa Fascículo - FashionistabyDoradesign
 
Detail cv patrick keyser 2016
Detail cv patrick keyser 2016Detail cv patrick keyser 2016
Detail cv patrick keyser 2016Pat Keyser
 
Tομέας Δομικών Έργων
Tομέας Δομικών ΈργωνTομέας Δομικών Έργων
Tομέας Δομικών Έργωνtasta21
 
eFolder Expert Series Webinar — Three Ways to Securely Share Files Using Busi...
eFolder Expert Series Webinar — Three Ways to Securely Share Files Using Busi...eFolder Expert Series Webinar — Three Ways to Securely Share Files Using Busi...
eFolder Expert Series Webinar — Three Ways to Securely Share Files Using Busi...eFolder
 

Andere mochten auch (8)

BlackBelt
BlackBeltBlackBelt
BlackBelt
 
Byco
BycoByco
Byco
 
Pinta&Usa Fascículo - Fashionista
Pinta&Usa Fascículo - FashionistaPinta&Usa Fascículo - Fashionista
Pinta&Usa Fascículo - Fashionista
 
Detail cv patrick keyser 2016
Detail cv patrick keyser 2016Detail cv patrick keyser 2016
Detail cv patrick keyser 2016
 
Charles d'alberto bmw x5
Charles d'alberto bmw x5Charles d'alberto bmw x5
Charles d'alberto bmw x5
 
Tομέας Δομικών Έργων
Tομέας Δομικών ΈργωνTομέας Δομικών Έργων
Tομέας Δομικών Έργων
 
150818-Ownerforaday
150818-Ownerforaday150818-Ownerforaday
150818-Ownerforaday
 
eFolder Expert Series Webinar — Three Ways to Securely Share Files Using Busi...
eFolder Expert Series Webinar — Three Ways to Securely Share Files Using Busi...eFolder Expert Series Webinar — Three Ways to Securely Share Files Using Busi...
eFolder Expert Series Webinar — Three Ways to Securely Share Files Using Busi...
 

Ähnlich wie ROP Fair Poster - Healthy and Diseased Brain

Biochemistry of Alzheimers disease
Biochemistry of Alzheimers diseaseBiochemistry of Alzheimers disease
Biochemistry of Alzheimers diseaseAshok Katta
 
Alzheimers disease by Ritika soni
Alzheimers disease by Ritika soniAlzheimers disease by Ritika soni
Alzheimers disease by Ritika soniShimla
 
Understanding the Brain.pdf
Understanding the Brain.pdfUnderstanding the Brain.pdf
Understanding the Brain.pdfe44101224
 
Alzheimers disease and its treatments
Alzheimers disease and its treatmentsAlzheimers disease and its treatments
Alzheimers disease and its treatmentsRavish Yadav
 
Alzheimerdisease and apoptosis
Alzheimerdisease and apoptosisAlzheimerdisease and apoptosis
Alzheimerdisease and apoptosiseman youssif
 
Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's diseaseSajed Tuhin
 
Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's diseasesarma jvsr
 
alzheimersdisease final.pptx
alzheimersdisease final.pptxalzheimersdisease final.pptx
alzheimersdisease final.pptxKomal Upreti
 
Alzheimer's disease.pptx
Alzheimer's disease.pptxAlzheimer's disease.pptx
Alzheimer's disease.pptxAman Kumar
 
What happens to the brain in Alzheimer’s Disease?
What happens to the brain in Alzheimer’s Disease?What happens to the brain in Alzheimer’s Disease?
What happens to the brain in Alzheimer’s Disease?Isabelle Alexe
 
Alzheimers presentation.docx
Alzheimers presentation.docxAlzheimers presentation.docx
Alzheimers presentation.docxHena Jawaid
 

Ähnlich wie ROP Fair Poster - Healthy and Diseased Brain (20)

Biochemistry of Alzheimers disease
Biochemistry of Alzheimers diseaseBiochemistry of Alzheimers disease
Biochemistry of Alzheimers disease
 
Alzheimers disease by Ritika soni
Alzheimers disease by Ritika soniAlzheimers disease by Ritika soni
Alzheimers disease by Ritika soni
 
Alzheimer's__CHANDAN.pptx
Alzheimer's__CHANDAN.pptxAlzheimer's__CHANDAN.pptx
Alzheimer's__CHANDAN.pptx
 
3429390.ppt
3429390.ppt3429390.ppt
3429390.ppt
 
Alzheimer disease
Alzheimer diseaseAlzheimer disease
Alzheimer disease
 
Alzheimers disease
Alzheimers diseaseAlzheimers disease
Alzheimers disease
 
Understanding the Brain.pdf
Understanding the Brain.pdfUnderstanding the Brain.pdf
Understanding the Brain.pdf
 
Alzheimers disease and its treatments
Alzheimers disease and its treatmentsAlzheimers disease and its treatments
Alzheimers disease and its treatments
 
Alzheimerdisease and apoptosis
Alzheimerdisease and apoptosisAlzheimerdisease and apoptosis
Alzheimerdisease and apoptosis
 
konstantinravvin89
konstantinravvin89konstantinravvin89
konstantinravvin89
 
Alzeihmer disease
Alzeihmer diseaseAlzeihmer disease
Alzeihmer disease
 
Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's disease
 
Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's disease
 
alzheimersdisease final.pptx
alzheimersdisease final.pptxalzheimersdisease final.pptx
alzheimersdisease final.pptx
 
Alzheimer's disease.pptx
Alzheimer's disease.pptxAlzheimer's disease.pptx
Alzheimer's disease.pptx
 
Microtubulos
Microtubulos Microtubulos
Microtubulos
 
Alzheimer
AlzheimerAlzheimer
Alzheimer
 
What happens to the brain in Alzheimer’s Disease?
What happens to the brain in Alzheimer’s Disease?What happens to the brain in Alzheimer’s Disease?
What happens to the brain in Alzheimer’s Disease?
 
Neurodegenerative disorders
Neurodegenerative disordersNeurodegenerative disorders
Neurodegenerative disorders
 
Alzheimers presentation.docx
Alzheimers presentation.docxAlzheimers presentation.docx
Alzheimers presentation.docx
 

ROP Fair Poster - Healthy and Diseased Brain

  • 1. 3 2 1 Abstract: Loss, sadness, and isolation – the devastating feelings 35 million Alzheimer’s patients worldwide must wrestle on a daily basis. Alzheimer’s is a neurodegenerative disease characterized by brain mass loss. Using Cobweb, a better understanding of the mechanisms that underliethis disease can be achieved, facilitating the creation of new treatments. According to the Amyloid Cascade Hypothesis, amyloid beta is the cause of this degeneration. Neurons, the cells in our nervous system, produce this transmembrane protein which a series of enzymes, namely beta secratase, cut and release. It then clumps and wreaks havoc on synapses, the connections between neurons. Normally, these proteins are swept out of the brain by cerebral spinal fluid (CSF), while in Alzheimer’s, there is a decrease in the efficiency of this cleaning mechanism, which we have been able to illustrate in Cobweb. As a result, amyloid beta aggregates and interferes in neuronal communication, becoming the catalyst for the formation of neurofibrillary tangles, which are dead nerve cells. Both of these phenomena are successfully realized in our model. The combination of plaques and tangles causes brain mass loss, the cause of the manifestation of symptoms. The Brain on COBWEB A Hierarchy, Revisited Alessandro Ricci, Melisa Gumus, Mazen El-Kurdi, Vernon Li, Victoria Agapova Supervisor: Dr. Brad Bass Purpose - To successfully model the progress of Alzheimer’s in the brain using Cobweb. Hypothesis - We hypothesize that we can monitor the brain of an Alzheimer’s patient from birth to neurodegeneration by illustrating its components on Cobweb, software originally meant to explore theoretical complex systems. Legend - Glucose- A Hippocampal Neuron - Cerebral Spinal Fluid (CSF) and interstitial fluid - Amyloid Beta (represented as a product of a neuron) - Cerebral Spinal Fluid (CSF) and interstitial fluid Results Fig 1 – A representation of the healthy adult brain in Cobweb. The top 4/5 of the image is the hippocampus with neurons and normally forming amyloid beta being produced and flushed away. Fig 2 – The final stage of Alzheimer’s, with significant brain cell loss, amyloid beta plaques, and neurofibrillary tangles (dead hippocampal neurons). Fig 3 – The graphical representation of the hippocampal cell count, with initial rapid growth representing early neurodevelopment (1), relative stabilization in adulthood (2), and the rapid decline in Alzheimer’s. (3) Fig 4 – An amyloid beta immunostain. Source : Grathwohl, S.A., Kälin, R.E., Bolmont, T., Prokop, S., Winkelmann, G., Kaeser, S.A., Odenthal, J., Radde, R., Eldh, T., Gandy, S., et al. (2009). Formation and maintenance of Alzheimer’s disease β-amyloid plaques in the absence of microglia. Nature Neuroscience 12, 1361–1363. Conclusion - Computer models afford a different perspective on human systems and difficult diseases. Alzheimer’s, being one of them. Scientists do not yet have a clear understanding of its onset or mechanism of destruction. A model created on Cobweb can act as a vessel through which potential treatments can be tested for efficacy. An important concern is the delicacy of a computer simulation, where adding another parameter, be it a treatment, may change the original project itself. Creating a more stable model is a critical goal for future research. Fig 1 - Propagation of one IPSP and three EPSPs coming from the dendrites Fig 2 - Propagation of IPSP outcompeting a sum of three EPSPs due to its strategic location close to an axon hillock Fig 3 - When no IPSP is present, the summation of three EPSPs causes neuron potential to reach threshold and activate action potential Post Synaptic Potential - Abstract: When using computerized simulations such as COBWEB to model brain activity, it is difficult to obtain an accurate representationof such a vast neural network. This idea stresses the importance of deconstruction and the separation of neural activity into the three basic signalling principles of action potential transmission, synaptic transmission and post synaptic potential propagation. An action potential is an event in which electrical charges across a cell membrane rises and falls. The change in membrane potential leads to the ability of electrical signalling in neurons. This model simulates one action potential between two neurons. It uses COBWEB to represent sodium and potassium movement which demonstrates the changes in membrane potential. The idea of ion movement in COBWEB is applied by the theory of predator prey models. With the execution of an action potential, the signal is carried downstream to the presynaptic membrane where neurotransmitters are released into the synaptic cleft. Synaptic transmission refers to the communication between two neurons via the synapse. When the action potential arrives at the axon terminal it alters the membrane potential in that area, which results in the release of neurotransmitters, which can then travel to the post synaptic membrane of another neuron and bind to receptors there. After that occurs it results in the initiation of another action potential in that neuron. Hence communication has occurred between the adjacent neurons. This model presents this phenomenon showing an action potential arriving at the axon terminal and subsequently being communicated to the next neuron. The opening of ion channels on the post synaptic membrane triggers Excitatory Postsynaptic Potentials (EPSPs) and allows the potential to reach a threshold that triggers action potential, whereas summation of Inhibitory Postsynaptic Potentials (IPSPs) prevents potential from reaching threshold thus inhibiting action potential. Not only is the amplitude of IPSPs and EPSPs important for signal propagation, but also the site of their arrival to cell soma. This simulation model demonstrates a single IPSP preventing action potential activation by three incoming EPSPs due to its beneficial location closer to the axon hillock. Figure 1: Yellow Agents (Potassium) and Blue Agents (Sodium) interacting at the peak of the action potential. This map shows the charge represented by agents. Because there are more blue agents (sodium) vs yellow (potassium), we can interpret that the charge at the peak of the action potential is mainly due to sodium. Figure 2: Blue agents (sodium) is no longer dominant and the figure above represents the phase of hyperpolarization. As depicted, there are more yellow agents (potassium) than blue agents (sodium). This means that the charge in the hyperpolarization phase is mainly due to the action of potassium. Figure 4: The effect of sodium and potassium ions inside the cell when forming an action potential. With an initial stimuli, sodium enters the cell represented by the orange curve. At first, sodium plays a larger role, but as the action potential continues, at 1000 ticks, potassium plays a bigger role when it comes to hyperpolarization. This is represented by the potassium count being greater than the sodium count. 0 500 1000 1500 2000 2500 0 200 400 600 800 1000 1200 1400 1600 Agent Count (K+/Na+) Time (Ticks) Amount of Sodium and Potassium Ions Inside the Cell Over Time. Potassium Sodium Figure 3: Representation of an action potential caused by the potassium and sodium movement across the cell membrane. The red line depicts the agents which are potassium and sodium and the red curve shows their effect together, thus resulting in an action potential. Action Potential - The Synapse - Healthy Brain Model Alzheimer’s Model Acknowledgements – We thank Dr. Brad Bass for his guidance and advice, and our research assistants Jason Ning and Angelina Pan for their help. ROP299 Fig 1 Fig 2 Fig 3 Fig 4